Skip to main content

D 86 (Divalproex Sodium Delayed Release 500 mg)

Pill with imprint D 86 is Pink, Elliptical/Oval and has been identified as Divalproex Sodium Delayed Release 500 mg. It is supplied by Aurobindo Pharma Limited.

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for D 86

Divalproex Sodium Delayed Release

D 86
500 mg
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Aurobindo Pharma Limited
Inactive Ingredients
silicon dioxide, microcrystalline cellulose, croscarmellose sodium, povidone k30, low substituted hydroxypropyl cellulose, magnesium silicate, methylene chloride, methacrylic acid - ethyl acrylate copolymer (1:1) type a, diethyl phthalate, hypromellose 2910 (15 mPa.s), triacetin, polyvinyl alcohol, titanium dioxide, polyethylene glycol 3350, soya lecithin, FD&C Red No. 40, vanillin, FD&C Blue No. 2, shellac, isopropyl alcohol, ferrosoferric oxide, butyl alcohol, propylene glycol, ammonia

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
65862-0403 Aurobindo Pharma Limited
68084-0782 Amerisource Health Services

Get help with Imprint Code FAQs.

Related images for "D 86"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.